GlobeNewswire: Conformis, Inc. Contains the last 10 of 204 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T12:22:32ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2023/09/05/2737334/0/en/restor3d-Completes-Acquisition-of-Conformis.html?f=22&fvtc=4&fvtv=26451restor3d Completes Acquisition of Conformis2023-09-05T12:18:31Z<![CDATA[Combination Creates the World’s Preeminent Producer of Personalized Orthopedic Medical Devices, with Unmatched Additive Manufacturing Capabilities Combination Creates the World’s Preeminent Producer of Personalized Orthopedic Medical Devices, with Unmatched Additive Manufacturing Capabilities]]>https://www.globenewswire.com/news-release/2023/08/23/2730372/0/en/Independent-Proxy-Advisory-Firms-ISS-and-Glass-Lewis-Recommend-Conformis-Stockholders-Vote-FOR-the-Pending-Merger-with-restor3d.html?f=22&fvtc=4&fvtv=26451Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3d2023-08-23T12:00:00Z<![CDATA[BILLERICA, Mass., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co., LLC (“Glass Lewis”), have each recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d.]]>https://www.globenewswire.com/news-release/2023/08/21/2729021/0/en/Independent-Proxy-Advisory-Firm-ISS-Recommends-Conformis-Stockholders-Vote-FOR-the-Pending-Merger-with-restor3d.html?f=22&fvtc=4&fvtv=26451Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d2023-08-21T20:10:25Z<![CDATA[BILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firm, Institutional Shareholder Services Inc. (“ISS”), has recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d.]]>https://www.globenewswire.com/news-release/2023/08/02/2717497/0/en/Conformis-Reports-Second-Quarter-2023-Financial-Results.html?f=22&fvtc=4&fvtv=26451Conformis Reports Second Quarter 2023 Financial Results2023-08-02T21:15:00Z<![CDATA[BILLERICA, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June 30, 2023.]]>https://www.globenewswire.com/news-release/2023/06/23/2693390/0/en/Conformis-Announces-Definitive-Agreement-to-be-Acquired-by-restor3d-for-a-Purchase-Price-of-2-27-Per-Share-in-Cash.html?f=22&fvtc=4&fvtv=26451Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash2023-06-23T02:05:08Z<![CDATA[Combination creates a leading personalized 3D-printed orthopedic medical device company Combination creates a leading personalized 3D-printed orthopedic medical device company]]>https://www.globenewswire.com/news-release/2023/05/08/2663266/0/en/Conformis-Reports-First-Quarter-2023-Financial-Results.html?f=22&fvtc=4&fvtv=26451Conformis Reports First Quarter 2023 Financial Results2023-05-08T12:05:00Z<![CDATA[BILLERICA, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2023.]]>https://www.globenewswire.com/news-release/2023/04/13/2646725/0/en/Conformis-Inc-to-Announce-Financial-Results-for-Its-First-Quarter-on-May-8-2023.html?f=22&fvtc=4&fvtv=26451Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 20232023-04-13T20:30:00Z<![CDATA[BILLERICA, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it will release its financial results for the first quarter ended March 31, 2023, before the market opens on Monday, May 8, 2023.]]>https://www.globenewswire.com/news-release/2023/03/21/2631130/0/en/Conformis-Launches-Patient-Awareness-Campaign-to-Highlight-the-Benefits-of-Personalized-Knee-Replacement-Procedures.html?f=22&fvtc=4&fvtv=26451Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures2023-03-21T11:00:00Z<![CDATA[The campaign underscores that patients have a choice of implant when undergoing total knee arthroscopy, and that they should advocate for the many benefits of a fully personalized knee The campaign underscores that patients have a choice of implant when undergoing total knee arthroscopy, and that they should advocate for the many benefits of a fully personalized knee]]>https://www.globenewswire.com/news-release/2023/03/01/2618723/0/en/Conformis-Inc-Reports-Fourth-Quarter-and-Year-End-2022-Financial-Results.html?f=22&fvtc=4&fvtv=26451Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results2023-03-01T21:05:00Z<![CDATA[BILLERICA, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the fourth quarter and year ended December 31, 2022.]]>https://www.globenewswire.com/news-release/2023/02/21/2612728/0/en/Conformis-Inc-to-Participate-in-Upcoming-Investor-Conferences.html?f=22&fvtc=4&fvtv=26451Conformis, Inc. to Participate in Upcoming Investor Conferences2023-02-21T21:15:00Z<![CDATA[BILLERICA, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate at two upcoming investor conferences.]]>